Home > PE Ratio > INNOVA CAPTAB

INNOVA CAPTAB
PE (Price/Earnings) Ratio

The Current P/E Ratio of INNOVA CAPTAB is 30.58.

Share Price ₹461.8May 13,2024
Market Cap ₹2,641.2 Cr
Earnings-TTM₹86.4 CrTTM-Consolidated Results
Price/Earnings30.58xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for INNOVA CAPTAB
Please provide your vote to see the results
INNOVA CAPTAB is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of INNOVA CAPTAB

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of INNOVA CAPTAB is calculated as :

Current Market Cap [ ₹2,641.2 Cr] as on May 13,2024

(/) Earnings [ ₹86.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 30.58x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for INNOVA CAPTAB , the investors are currently willing to pay 30.58 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INNOVA CAPTAB !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of INNOVA CAPTAB over the last five years.

Historical PE (Price/Earnings) ratio chart of INNOVA CAPTAB


PE Ratio Performance Analysis for INNOVA CAPTAB

- INNOVA CAPTAB 's latest p/e ratio is 30.58x.

- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.00x.

- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2023 at 0x.

- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does INNOVA CAPTAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
INNOVA CAPTAB 86.3830.582,641.2
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.68366,103.0
CIPLA LTD4,155.3127.49114,230.0
DR REDDYS LABORATORIES LTD5,563.2017.7598,732.2
ZYDUS LIFESCIENCES LTD2,954.2033.8399,939.2
DIVIS LABORATORIES LTD1,382.9775.14103,916.0
MANKIND PHARMA LTD1,743.3050.0987,324.4
TORRENT PHARMACEUTICALS LTD1,494.0059.0088,139.6
LUPIN LTD1,935.5739.7476,919.2
AUROBINDO PHARMA LTD2,777.8924.8469,014.8
ABBOTT INDIA LTD1,201.2247.8457,465.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INNOVA CAPTAB 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.75x
Max industry PE 75.14x
Median industry PE 39.74x
Average industry PE 40.63x



You may also like the below Video Courses